ANXA5 and hepatocellular carcinoma: In previous findings, Annexin A5 (ANXA5) plasma levels were investigated as a potential biomarker for asthma diagnosis [109], pregnant and non-pregnant subjects [110], as well as for liver cirrhosis and hepatocellular carcinoma [111].